Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Intraosseous therapy: harnessing the potential of tissue regeneration and repair

Artamonov MY., Minenko IA.

Narrative Review on Face & Skin, Back & Spine, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Med (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42180785
PMCID
PMC13193979
DOI
10.3389/fmed.2026.1775823

Abstract (original English)

Tissue regeneration and repair remain significant challenges in various medical fields, particularly in the context of musculoskeletal conditions. Intraosseous therapy has emerged as a promising approach, harnessing the body's intrinsic regenerative potential to promote bone and tissue regeneration. This review provides a comprehensive overview of intraosseous therapy, including its principles, strategies, and clinical applications. The bone biology and regeneration processes are discussed, along with the roles of cellular components such as osteoblasts, osteoclasts, osteocytes, and mesenchymal stem cells. Intraosseous therapy encompasses various approaches, including Bone marrow aspirate concentrate (BMAC), platelet-rich plasma (PRP), stem cell-based therapies (mesenchymal stem cells, induced pluripotent stem cells, and other sources), biomaterials and scaffolds, and growth factors. The clinical applications of intraosseous therapy span bone fracture repair and non-union, spinal fusion, craniofacial and maxillofacial reconstruction, osteonecrosis and avascular necrosis, and osteoporosis and bone defects. While intraosseous therapy holds significant promise, challenges related to regulatory and ethical considerations, standardization and quality control, clinical translation and commercial viability, and future research directions in personalized medicine, advanced biomaterials

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research